We report the diagnostic evaluation, management, and intermediate-term outcomes of a rare variant of bladder cancer and concomitant Abdominal Aortic Aneurysm. A 62 year old male with gross haematuria and Abdominal Aortic Aneurysm was admitted to our hospital. Cystoscopy revealed a large bulky mass occupying the posterior bladder wall. The tumor was transurethrally resected and its histology showed a Sarcomatoid Carcinoma of the urinary bladder. Due to the aggressive behavior of the tumor and the risk of aneurysm rupture, concomitant endovascular exclusion of Aneurysm, total cystectomy with urinary diversion was performed. 12 months after radical surgery the patient was alive without any local recurrence, distant metastasis, and thrombosis of iliac axis . To our knowledge this study is the first report to describe data on the diagnostic evaluation, Management, and intermediate-term outcomes in Sarcomatoid carcinoma and Concomitant Abdominal Aortic Aneurysm. Multi-institutional collaboration is important to perform clinical trials of adequate sample size to design more effective treatments for these aggressive cancers in the presence of Concomitant Abdominal Aortic Aneurysm.
Introduction
The Sarcomatoid Carcinoma of the urinary bladder is a rare variant (incidence < 0.1%) of urothelial carcinoma with aggressive malignant potential and poor prognosis [1] .
Because of the rarity of this neoplasm in which both the histogenesis and biological behavior remain controversial, uncertainty exists regarding treatment and prognosis [2] [3] [4] [5] .
We report a case of bladder cancer of the sarcomatoid variant in a 62 year old male with Abdominal Aortic Aneurysm, and we present the diagnostic evaluation, management, and intermediate-term outcomes.
Material and Methods
A 62 year old male with gross haematuria was admitted to our hospital. In the clinical history Abdominal Aortic Aneurysm (maximum diameter 7.4 cm) and coronary heart disease with former myocardial infarct were remarkable.
Cystoscopy revealed a non-papillary large bulky mass occupying the posterior bladder wall with a necrotic tumor surface. Abdominal Computed tomography demonstrated a solid mass (maximum diameter 5 cm) with colliquative-necrotic areas in the posterior wall of the bladder involving the perivesical adipose tissue and external and internal iliac lymph nodes. The thoracic computed tomography was negative for metastatic lesions. The tumor was transurethrally resected and its histology showed a primitive undifferentiated cancer with Sarcomatoid areas infiltrating the muscle layer ( Figure 1 ). Due to the aggressive behavior of Sarcomatoid cancer and the risk of aneurysm rupture, concomitant endovascular exclusion of Abdominal Aortic Aneurysm, total cystectomy with urinary diversion (according to Bricker), and pelvic lymph nodal dissection was performed.
Results
Gross examination of the bladder showed an ulcerated mass (size 8 cm x 6 cm x 6 cm) with hemorrhagic area infiltrating the perivesical adipose tissue. The lymph nodes and resected margins were negatives for neoplastic infiltration. Histological examination of the bladder mass confirmed the diagnosis of Sarcomatoid Carcinoma infiltrating the muscle layer and perivesical adipose tissue. Microscopically, the tumor was a high grade urothelial carcinoma, Grade III (stage pT3a). A large subset of the tumor assumed a spindle cell/ sarcomatoid appearance with high mitotic rate and atypical mitoses.
Immunohistochemically the tumor cells were positive for the Epithelial Membrane Antigen (EMA), Cytokeratins (CK1 , CK3 ,CK7 , CK20) and Vimentin , and were negative for a-Smooth Muscle Actin (a-SMA) ( Figure 2 ). The immunohistochemical positiveness for CK 7 were a credit for a primitive cancer of the bladder. These histologic and immunohistochemical evidences of both epithelial and mesenchymal differentiation classify this tumor as sarcomatoid variant of urothelial carcinoma.
The patient was alive without any local recurrence and distant metastasis 12 months after radical surgery. 
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Haematoxylin and eosin sections show biphasic morphology characteristic of this rare variant : Malignant undifferentiated epithelial components and invasive sarcomatoid components (A ,20 X). The sarcomatoid component is formed of fascicles of fusiform cells and atypical pleomorphic spindle cells with atypical mitoses (B, 40 X ), high mitotic rate (C,20 X) , and extensive necrosis (D,20 X)
Sarcomatoid Abdominal vascular CT showed aortic stent without thrombosis and regular opacity of iliac axis, bilaterally for the same period of follow-up.
Discussion
Sarcomatoid Carcinoma of the urinary bladder is a rare variant of urothelial carcinoma (incidence < 0.1%) which exhibits biphasic epithelial and mesenchymal differentiation and affect the late decades of life [1, [6] [7] [8] .
The median age at diagnosis is 66 (50-77) years with a male: female ratio of 4:1. The most frequent presenting signs and symptoms are hematuria ( 70%), dysuria (22%), lower abdominal pain (4%) and nocturia ( 4%) [3] .
At initial diagnosis, almost all patients presented frequently with the advanced stage disease and distant metastases [9] .
In the records of Mayo Clinic of the 26 patients with Sarcomatoid Carcinoma follow up revealed that 81% died of at a mean of 9.8 months [3] . Most patients died of local disease or of lymph node, lung, pleura, brain, liver, and bone metastases [9] .
The incidence rate of concomitant Aortic Aneurysm and bladder cancer is 3% in literature and the optimal surgical approach is debated [10] . This is the first report of bladder sarcomatoid variant diagnosed in a male patient with Abdominal Aortic Aneurysm, at risk of rupture.
The risk of aneurismal rupture depends on its dimensions: lower than 3% for aneurysms lower than 5 cm in diameter, 10% per year for aneurysms greater than 5 cm in diameter [11] .
Because of the rarity of the Sarcomatoid Carcinoma uncertainty exists regarding treatment and prognosis. Radical Cystoprostatectomy with lymphadenectomy is the treatment of choice, although several patients developed metastasis after surgery. Nevertheless the literature for nonsurgical therapy for these bladder tumors is not conclusive [4, 12] .
The main controversy in this case report revolves around whether to treat the bladder sarcomatoid cancer and the Abdominal Aortic Aneurysm simultaneously or as staged procedures and the possible toxicity for adjuvant or neoadjuvant therapy in the presence of concomitant Abdominal Aortic Aneurysm.
Radical surgery as individual procedure without concomitant aneurism repair may determine aneurysm enlargement till the rupture due to increased activity of elastase and hyaluronidase which negatively influence the arteries wall.
Subsequent aneurysm repair may also risk ureteral or bowel injury because of the presence of urinary diversion and cicatricial obliteration or vascular compromise [10] .
Adjuvant or neoadjuvant chemotherapy can injure the vessel for the excess of liquids or systemic toxicity; adjuvant or neoadjuvant radiotherapy can activated phlogosis factors, proteolytic enzymes or free radicals.
Simultaneous cystectomy, urinary diversion, and aneurism repair is a difficult procedure with the potential for graft infection from spilled bowel contents and urine.
Endovascular endoprosthesis , as in our case, could solve the problem ; unfortunately not all aneurysms are anatomically suitable for endovascular repair [10, 13] .
In our case abdominal vascular CT showed aortic stent without endoluminal thrombotic apposition and regular opacity of iliac axis, bilaterally for the whole period of follow-up. Nevertheless the optimal management for this rare and aggressive neoplasm is uncertain.
To our knowledge this study is the first report to describe data on the diagnostic evaluation, management, and intermediate-term outcomes in Sarcomatoid carcinoma and Concomitant Abdominal Aortic Aneurysm.
Multi-institutional collaboration is important to perform clinical trials of adequate sample size to design more effective treatments for these aggressive cancers in the presence of Concomitant Abdominal Aortic Aneurysm at high risk of rupture.
